A coroner has recommended that the Health Products Regulatory Authority continues its investigations into the side effects of Glatiramer Acetate , sold under the brand name Copaxone, a drug commonly used in the management of multiple sclerosis .
Geraldine Maloney, Consultant Anaesthetist at MUH, gave evidence that Ms Quinn was admitted on February 9th, 2022 to intensive care following an out of hospital cardiac arrest. Dr Tighe said that in light of the fact that Ms Quinn collapsed shortly after receiving the drug it was possible it was the cause of the anaphylactic shock.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: